Vertex Pharmaceuticals
VRTX
#175
Rank
ยฃ87.66 B
Marketcap
ยฃ341.91
Share price
-0.41%
Change (1 day)
-5.15%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): ยฃ3.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are ยฃ11.72 Billion. In 2024 the company made an earning of ยฃ0.20 Billion a decrease over its 2023 earnings that were of ยฃ3.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ3.38 B1513.87%
2024 ยฃ0.20 B-93.69%
2023 ยฃ3.32 B3.19%
2022 ยฃ3.21 B53.56%
2021 ยฃ2.09 B-12.06%
2020 ยฃ2.38 B118.45%
2019 ยฃ1.09 B120.64%
2018 ยฃ0.49 B1473.64%
2017 ยฃ31.42 M197.6%
2016 ยฃ10.55 M-102.97%
2015 -ยฃ0.36 Billion-28.46%
2014 -ยฃ0.5 Billion-51.5%
2013 -ยฃ1.03 Billion-30584.68%
2012 ยฃ3.36 M-95.47%
2011 ยฃ74.23 M
2009 -ยฃ0.45 Billion
2007 -ยฃ0.31 Billion83.1%
2006 -ยฃ0.17 Billion59.02%
2005 -ยฃ0.11 Billion3.28%
2004 -ยฃ0.11 Billion-38.16%
2003 -ยฃ0.17 Billion
2000 -ยฃ28.56 Million-20.38%
1999 -ยฃ35.87 Million31.62%
1998 -ยฃ27.25 Million91.05%
1997 -ยฃ14.27 Million-36.24%
1996 -ยฃ22.37 Million12.45%
1995 -ยฃ19.9 Million27.4%
1994 -ยฃ15.62 Million-1833.33%
1993 ยฃ0.9 M-112.12%
1992 -ยฃ7.44 Million175%
1991 -ยฃ2.71 Million-12.2%
1990 -ยฃ3.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
ยฃ7.42 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.24 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.33 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.31 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-ยฃ64.71 Million-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA